Replies to post #7351 on Halozyme Therapeutics Inc (HALO)

[Fred Kadiddlehopper]

Helen was not on her game at this presentation. The one positive I took out of it was the three new deals. I'm not her biggest fan, but when she says things like that they usually become reality. The only question is how large the deals will be or, if moderate in scale, will they represent a new and impactful class of collaboration. Stay tuned.

[easycomeandgo]

Your point as to the wording of the HALO news release well taken. Investors will have to make up their own minds. As an aside, for example, it is not uncommon for individuals to gracefully resign following persuasive guidance or prior agreement.

As to what will be the situation 4-5 years from now, and forecasting stock prices based on that, let us just say that paper is patient, it accepts anything. The facts are that, despite cash compensation which is not miserly, and independent wealth in some cases, management shows less patience or conviction and, generally, cashes in the stock grants as soon as they are received. Further, if the Enhanze business is such a sure fire thing, I don‘t understand the cash purchase of a less than thriving and no longer patent protected auto injector business. I wrote at the time that it makes sense under less certain “Enhanze alone” guaranteed circumstances and then only just and depending on further, patentable, product development.

I would agree that the future is more nebulous than the $ 7 or 8 earnings per share forecast would lead the reader to believe.